Retinal Physician

JAN-FEB 2017

Issue link: http://retinalphysician.epubxp.com/i/783300

Contents of this Issue

Navigation

Page 68 of 71

agulation treatments can be completed using infrared illu- mination, which results in a significant reduction in pain perceived by the patient, according to the company website. Also, the increased speed of Navilas results in shorter treatments. In the short term, patients benefit from 30% increased accuracy compared to conventional lasers. 1 Furthermore, many treatments can be completed in a single session, attain- ing a faster and further reduction in central retinal thickness and 40% fewer retreatments compared to conventional laser delivery. 2 If used in conjunction with anti-VEGF injections, Navilas significantly lowers the treatment burden, reducing the amount of injections required by 75% over traditional monotherapy, supporting better long-term outcomes. 3 e Navilas-guided laser has also led to fewer pharmacotherapy injections, as suggested by several studies, Dr. Brown adds. e TREX DME study, 4 underway at multiple centers, is expected to provide guidance on the magnitude and dura- tion of this response. USER-FRIENDLY PLANNING AND TREATMENT e software in the newly approved Navilas 577s makes the planning and treatment phase seamless, with quicker treatment planning than with the original device, Dr. Brown says. "e smaller optical head [compared to the Navilas 577+] allows surgeons to see the patient better, ensuring improved communication." e 577s' technology enables high-resolution imaging of the retina with a large field of view throughout treatment, resulting in enhanced visual- ization compared to conventional slit-lamp-based lasers, which only partially visualize the retina. Physicians can access functions directly on the touchscreen, as well as by using buttons on the base and joystick. During the learn- ing phase, both the trainer and trainee can watch the screen, instead of viewing through an observation tube. is enables direct communication and gives the trainer the opportunity to identify potential mistakes before laser energy is applied. e navigation also allows physicians to block sensitive areas with exclusion zones and to digitally document every laser spot. At any point during or after treatment, colleagues and even patients can be involved in the treatment by review- ing the plan and spot locations. e final treatment result can be easily printed or shared electronically with referring physicians. RP REFERENCES 1. Kozak I, Oster SF, Cortes MA, et al. Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS. Ophthalmology. 2011;118(6):1119-1124. 2. Neubauer AS, Langer J, Liegl R, et al. Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser. Clin Ophthalmol. 2013;7:121-128. 3. Liegl R, Langer J, Seidensticker F, et al. Comparative evaluation of combined navigated laser photocoagulation and intravitreal ranibizumab in the treatment of diabetic macular edema. PLoS One. 2014;9(12):e113981. 4. Payne JF, Wykoff CC, Clark WL, Bruce BB, Boyer DS, Brown DM; TREX-DME Study Group. Randomized trial of treat and extend Ranibizumab with and with- out navigated laser for diabetic macular edema: TREX-DME 1 year outcomes. Ophthalmology. 2017;124(1):74-81. RP ADVERTISING INDEX JANUARY-FEBRUARY 2017 AbbVie, Inc. ..................................................................... 30-34 www.abbvie.com Bausch & Lomb .....................................................................23 www.bausch.com Dutch Ophthalmic ...............................Inside Front Cover www.dorc.eu European Vitreo Retinal Society .................................... 63 www.evrs.eu Genentech ............................................................................ 2-3 www.lucentis.com/hcp Heidelberg Engineering .................................. Back Cover www.HeidelbergEngineering.com Leica Microsystems Inc. ................ 68-Inside Back Cover www.leica-microsystems.com MedOne .................................................................................41 www.MedOne.com Nidek .......................................................................................... 7 www.nidek.com Oculus Surgical ......................................................................25 www.oculussurgical.com OD-OS.....................................................................................13 www.navilas.com Regeneron ..........................................................................9-10 www.regeneron.com Retina World Congress ......................................................53 retinaworldcongress.org Topcon ....................................................................................43 www.topcon.com R E S O U R C E CENTER BUSINESS OPPORTUNITIES For more information please contact: Ryan Langton Phone: 267-692-7744 ryan.langton@pentavisionmedia.com FOR SALE! High volume medical and surgical eye practice for sale in Orlando, Florida. Established 45 years. Email: dcopely7@gmail.com Cell: 321-299-6315(6316) 67 R E T I N A L P H Y S I C I A N . C O M | J A N U A R Y / F E B R U A R Y 2 0 1 7

Articles in this issue

Links on this page

Archives of this issue

view archives of Retinal Physician - JAN-FEB 2017